Advances in cancer research. Volume 95 [electronic resource] / edited by George F. Vande Woude, George Klein.
Material type:
TextSeries: Advances in cancer research ; v. 95Publication details: New York : Academic Press, 2006. Description: 1 online resource (xi, 358 p.) : illISBN: 0120066955 (electronic bk.); 9780120066957 (electronic bk.)Subject(s): Cancer -- Research | Oncology | Cancer -- Research | OncologyGenre/Form: Electronic books.DDC classification: 616.99/40072 LOC classification: RC267 | .A45 2006ebOnline resources: ScienceDirect Summary: The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including NY-ESO-1: review of an immunogenic tumor antigen; Order, disorder, death: lessons from a superorganism; Control of differentiation in progression of epithelial tumors; Cancer vaccines: preclinical studies and novel strategies; Clinical results of vaccine therapy for cancer: learning from history for improving the future; Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell based cancer vaccines; NK cell receptors as tools in cancer immunotherapy; Innate immune recognition and suppression of tumors; Inhibitors of the HSP90 molecular chaperone: current status.
Includes bibliographical references and index.
Description based on print version record.
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including NY-ESO-1: review of an immunogenic tumor antigen; Order, disorder, death: lessons from a superorganism; Control of differentiation in progression of epithelial tumors; Cancer vaccines: preclinical studies and novel strategies; Clinical results of vaccine therapy for cancer: learning from history for improving the future; Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell based cancer vaccines; NK cell receptors as tools in cancer immunotherapy; Innate immune recognition and suppression of tumors; Inhibitors of the HSP90 molecular chaperone: current status.
There are no comments on this title.